Comparing Chemotherapy Recovery at Home versus in the Hospital for Children with Acute Myeloid Leukemia

Getz, Kelly; Szymczak, Julia E.; Contractor, Farah; Fisher, Brian T.; Aplenc, Richard

doi:10.25302/01.2021.cer.140922827

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A survey of family support structures was added to prospective assessments part way through the prospective cohort study in response to themes identified in semi‐structured interviews with patients and caregivers. 22 , 23 Thus, information on support structures was available for a subset of families. As support structures may influence HRQOL, a post hoc assessment of support structures by income categories was performed (Table S1 ).…”

Section: Methodsmentioning

confidence: 99%

Household income and health‐related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research

Newman,

Li,

Huang

et al. 2024

Cancer Medicine

Self Cite

View full text Add to dashboard Cite

ObjectiveExamine the influence of household income on health‐related quality of life (HRQOL) among children with newly diagnosed acute myeloid leukemia (AML).DesignSecondary analysis of data prospectively collected from pediatric patients receiving treatment for AML at 14 hospitals across the United States.ExposureHousehold income was self‐reported on a demographic survey. The examined mediators included the acuity of presentation and treatment toxicity.OutcomeCaregiver proxy reported assessment of patient HRQOL from the Peds QL 4.0 survey.ResultChildren with AML (n = 131) and caregivers were prospectively enrolled to complete PedsQL assessments. HRQOL scores were better for patients in the lowest versus highest income category (mean ± SD: 76.0 ± 14 household income <$25,000 vs. 59.9 ± 17 income ≥$75,000; adjusted mean difference: 11.2, 95% CI: 2.2–20.2). Seven percent of enrolled patients presented with high acuity (ICU‐level care in the first 72 h), and 16% had high toxicity (any ICU‐level care); there were no identifiable differences by income, refuting mediating roles in the association between income and HRQOL. Enrolled patients were less likely to be Black/African American (9.9% vs. 22.2%), more likely to be privately insured (50.4% vs. 40.7%), and more likely to have been treated on a clinical trial (26.7% vs. 18.5%) compared to eligible unenrolled patients not enrolled. Evaluations of potential selection bias on the association between income and HRQOL suggested differences in HRQOL may be smaller than observed or even in the opposing direction.ConclusionsWhile primary analyses suggested lower household income was associated with superior HRQOL, differential participation may have biased these results. Future studies should partner with patients/families to identify strategies for equitable participation in clinical research.

show abstract

Section: Methodsmentioning

confidence: 99%